Phase II study of high-dose cyclophosphamide in relapsing and/or resistant hepatoblastoma in children: a study from the SIOPEL group-Reference-Cited by-同舟云学术

Phase II study of high-dose cyclophosphamide in relapsing and/or resistant hepatoblastoma in children: a study from the SIOPEL group

Published:2004-10 Issue:15 Volume:40 Page:2274-2279
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Cacciavillano Walter Daniel,Brugières Laurence,Childs Margaret,Shafford Elisabeth,Brock Penelope,Pritchard Jon,Mailbach Rudolf,Scopinaro Marcello,Perilongo Giorgio

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Liver tumors;Perilongo;Eur. J. Cancer,1999

2. Primary liver tumors in children;Vos;Eur. J. Surg. Oncol,1995

3. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group;Schnater;Cancer,2002

4. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach – results of the first prospective study of International Society of Pediatric Oncology;Pritchard;J. Clin. Oncol,2000

5. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the children cancer study group;Ortega;J. Clin. Oncol,1991

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution;eClinicalMedicine;2024-03

2. Hepatoblastoma relapses after front-line therapy according to SIOPEL protocols: clinical characteristics and outcome;Pediatric Hematology/Oncology and Immunopathology;2020-12-22

3. Mechanisms of Anticancer Drug Resistance in Hepatoblastoma;Cancers;2019-03-22

4. Cerebral Metastasis of Hepatoblastoma: A Review;Journal of Pediatric Hematology/Oncology;2016-05

5. Outcomes of Patients With Relapsed Hepatoblastoma Enrolled on Children’s Oncology Group (COG) Phase I and II Studies;Journal of Pediatric Hematology/Oncology;2016-04